Last modified on 12 January 2007.

Financial Support for This Work:

  • National Institutes of Health (Grant #s GM48207 and GM067317, to RRG).
  • Isis Pharmaceuticals (to RRG).
  • Startup Funds from the University of Texas at Austin (Institute for Cellular and Molecular Biology) (to RRG).
  • Welch Foundation (Grant # F-1427, to RRG).
  • National Science Foundation (Grant # MCB-0110252, to RRG).
  • Microsoft Research (to RRG)